Karaciğer yetersizliğinin en etkili tedavisi karaciğer naklidir. Karaciğer nakli sonrasında erken ve geç dönem ciddi komplikasyonlar ortaya çıkabilmekte, bu durum hasta ve hasta yakınlarının bakımda zorluk yaşamasına, rejeksiyon ve enfeksiyon gibi nakledilen organın işlevinin kaybına neden olan ciddi sorunların ortaya çıkmasına neden olabilmektedir. Hastanın gereksinimlerine yönelik, öz yönetimin geliştirilmesine odaklı ekip çalışması ile gerçekleştirilen etkili bir taburculuk eğitimi komplikasyonları, tekrarlı yatışları ve greft kaybını önlemektedir. Taburculuk eğitimi, hasta ve yakınlarının beklentileri, öncelikleri ve gereksinimleri dikkate alındığında etkili olabilmektedir. Hemşireler, sağlık ekibi içinde nakil hastalarının taburculuk eğitiminde kilit noktadadırlar ve taburculuk sonrası dönemin yönetilmesinde önemli sorumlulukları bulunmaktadır. Özellikle rejeksiyon ve enfeksiyon gibi komplikasyonlar yaşamı tehdit eden ciddi sorunların ortaya çıkmasına neden olabilmektedir. İlaç uyumu ise bu komplikasyonların önlenmesinde büyük önem taşımaktadır. Hastalar, ameliyat sonrası çok sayıda ilaç kullanmakta ve başta ilaçların yan etkileri olmak üzere farklı nedenlerle ilaçları düzenli kullanmamakta ya da ilaçları bırakmaktadırlar. İlaç yönetimi, hemşirelerin önemli sorumluluklarındandır ve hemşireler ilaç yönetimi konusunda hastaları taburculuk sonrası dönemde de desteklemelidir. Benzer şekilde enfeksiyon karaciğer nakli olan hastalarda morbidite ve mortalitenin en önemli nedenlerinden biridir. Enfeksiyonların önlenmesi ise yine etkili bir taburculuk eğitimi ile mümkün olacaktır. Bu makalede, karaciğer nakli olan hastalar ve yakınlarına yönelik taburculuk eğitimi kapsamında yer alması gereken konular ele alınmış olup taburculuk eğitimi sürecinde hemşirelere katkı sağlayacağı öngörülmektedir.
Anahtar Kelimeler: Hastanın taburcu olması; hemşirelik; karaciğer nakli
The most effective treatment for liver failure is liver transplantation. Serious complications may occur early and late after liver transplantation, and this can lead to serious problems that cause patients and their relatives to have difficulty in care, loss of function of the transplanted organ such as rejection and infection. Effective discharge training/education, which is based on the needs of the patient, focused on the development of self-management, and which is carried out by teamwork, prevents complications, repeated hospitalization and loss of grafts. Discharge training can be effective considering the expectations, priorities and needs of patients and their relatives. Nurses are at the key point in transplant patients' discharge training within the healthcare team and have important responsibilities in managing the post-discharge period. Complications, especially rejection and infection, can lead to serious life-threatening problems. Medication compliance is of great importance in preventing these complications. Patients use a large number of drugs after surgery, and patients do not regularly use or discontinue drugs for different reasons, especially side effects of drugs. Medication management is one of the important responsibilities of nurses and nurses should support patients in medication management in the post-discharge period. Similarly, infection is one of the most important causes of morbidity and mortality in patients with liver transplantation. Prevention of infections will be possible with effective discharge training. In this article, the subjects that should be included focused discharge training for patients with liver transplantation and their relatives are discussed and it is predicted that they will contribute to the nurses during the discharge training.
Keywords: Patient discharge; nursing; liver transplantation
- Bhat M, Al-Busafi S, Deschênes M, Ghali P. Care of the liver transplant patient. Can J Gastroenterol Hepatol. 2014;28(4):213-9.[Crossref] [PubMed] [PMC]
- Emre ŞH, Umman V. Erişkin ve çocuklarda karaciğer transplantasyonu. Abbasoğlu O, editör. Karaciğer, Safra Yolları ve Pankreas Cerrahisi. 1. Baskı. Ankara: Dünya Tip Kitapevi; 2019. p.185-202.
- Golfieri L, Gitto S, Vukotic R, Andreone P, Marra F, Morelli MC, et al. Impact of psychosocial status on liver transplant process. Ann Hepatol. 2019;18(6):804-9.[Crossref] [PubMed]
- Global Observatory Donation and Transplantation. International Report on organ donation and transplantation: executive report. 2017. p.24-6.[Link]
- Türkiye Transplantasyon ve Diyaliz İzleme Sistemleri. Türkiye transplantasyon, diyaliz ve izlem sistemleri (TTDİS). Sayılarla TTDIS. Ankara: Türkiye Sağlık Bakanlığı; 2019. p.10.
- Frank-Bader M, Beltran K, Dojlidko D. Improving transplant discharge education using a structured teaching approach. Prog Transplant. 2011;21(4):332-9.[Crossref] [PubMed]
- Lucey MR, Terrault N, Ojo L, Hay JE, Neuberger J, Blumberg E, et al. Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Liver Transpl. 2013;19(1):3-26.[Crossref] [PubMed]
- Ko D, Bratzke LC, Muehrer RJ, Brown RL. Self-management in liver transplantation. Appl Nurs Res. 2019;45:30-8.[Crossref] [PubMed]
- Kelly DM, Bennett R, Brown N, McCoy J, Boerner D, Yu C, et al. Predicting the discharge status after liver transplantation at a single center: a new approach for a new era. Liver Transpl. 2012;18(7):796-802.[Crossref] [PubMed]
- Sá AS, Ziviani LC, Castro-E-Silva O, Galvão CM, Mendes KD. Information needs of family caregivers regarding liver transplant candidates. Rev Gaucha Enferm. 2016;37(1):e54650.[Crossref] [PubMed]
- Neuberger JM, Bechstein WO, Kuypers DR, Burra P, Citterio F, De Geest S, et al. Practical recommendations for long-term management of modifiable risks in kidney and liver transplant recipients: A guidance report and clinical checklist by the consensus on managing modifiable risk in transplantation (COMMIT) group. Transplantation. 2017;101(4S Suppl 2):S1-S56.[Crossref] [PubMed]
- Espinasse G, Kamar N, Hurault C, Suc B, Fourtanier G, Montastruc JL, et al. Drug exposure and perceived adverse drug events reported by liver-transplant patients. Int J Clin Pharmacol Ther. 2009;47(3):159-64.[Crossref] [PubMed]
- Geng L, Wang LD, Huang JJ, Shen T, Wang ZY, Lin BY, et al. Lower tacrolimus trough levels in the late period after living donor liver transplantation contribute to improvements in long-term clinical outcomes. Hepatobiliary Pancreat Dis Int. 2018;17(3):204-9.[Crossref] [PubMed]
- Jain M, Venkataraman J, Reddy MS, Rela M. Determinants of medication adherence in liver transplant recipients. J Clin Exp Hepatol. 2019;9(6):676-83.[Crossref] [PubMed] [PMC]
- Hreńczuk M, Bieniak A, Pazik J, Małkowski P. Analysis of health behaviors in patients after liver transplant. Transplant Proc. 2018;50(10):3587-93.[Crossref] [PubMed]
- Whitsett M, Levitsky J. Medication nonadherence in liver transplantation. Clin Liver Dis (Hoboken). 2018;10(6):157-60.[Crossref] [PubMed] [PMC]
- Hammad A, Kaido T, Aliyev V, Mandato C, Uemoto S. Nutritional therapy in liver transplantation. Nutrients. 2017;9(10):1126.. Erratum in: Nutrients. 2018;10(12).[Crossref] [PubMed] [PMC]
- Kosmach B, Koziolek C, McGhee L, Bakken L. A Guide to Your Health Care After Liver Transplantattion. USA, Chicago: International Nurses Transplant Society; 2016.
- European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu. EASL Clinical Practice Guidelines: Liver transplantation. J Hepatol. 2016;64(2):433-85.[Crossref] [PubMed]
- Alves BC, Bruch-Bertani JP, Galinatti CBM, Garbin CC, Álvares-da-Silva MR, Dall'Alba V. Obesity, dynapenia and high cardiovascular risk co-exist in post-liver transplant setting: results of a cross-sectional study. Clin Res Hepatol Gastroenterol. 2019;43(2):140-7.[Crossref] [PubMed]
- Ferreira SC, de Oliveira Penaforte FR, Cardoso A, da Silva MVT, Lima AS, Correia MITD, et al. Association of food cravings with weight gain, overweight, and obesity in patients after liver transplantation. Nutrition. 2020;69:110573.[Crossref] [PubMed]
- Mizuno Y, Ito S, Hattori K, Nagaya M, Inoue T, Nishida Y, et al. Changes in muscle strength and six-minute walk distance before and after living donor liver transplantation. Transplant Proc. 2016;48(10):3348-55.[Crossref] [PubMed]
- Parhar KS, Gibson PS, Coffin CS. Pregnancy following liver transplantation: review of outcomes and recommendations for management. Can J Gastroenterol. 2012;26(9):621-6.[Crossref] [PubMed] [PMC]
- Zaffar N, Soete E, Gandhi S, Sayyar P, Van Mieghem T, D'Souza R. Pregnancy outcomes following single and repeat liver transplantation: An international 2-center cohort. Liver Transpl. 2018;24(6):769-78.[Crossref] [PubMed]
- Dumortier J, Dedic T, Erard-Poinsot D, Rivet C, Guillaud O, Chambon-Augoyard C, et al. Pregnancy and donor-specific HLA-antibody-mediated rejection after liver transplantation: "Liaisons dangereuses"? Transpl Immunol. 2019;54:47-51.[Crossref] [PubMed]
- Spengler EK, Abouljoud M, Brown R, Davis G, Fontana R, Friedman E, et al. Getting a new liver: Facts about liver transplants. Patient Education. American Society of Transplantation. 2017;7-10.[Link]
- Baganate F, Beal EW, Tumin D, Azoulay D, Mumtaz K, Black SM, et al. Early mortality after liver transplantation: Defining the course and the cause. Surgery. 2018;164(4):694-704.[Crossref] [PubMed]
- Haddad L, Marciano S, Cleres M, Zerega A, Pi-ero F, Orozco F, et al. Characteristics of Liver Transplantation in Argentina: A Multicenter Study. Transplant Proc. 2018;50(2):478-84.[Crossref] [PubMed]
- Leong LY, Lin PC, Chi CY, Chou CH, Lu MC, Liao WC, et al. Risk factors of tuberculosis after liver transplant in a tertiary care hospital. J Microbiol Immunol Infect. 2019:S1684-1182(19)30139-2.[PubMed]
- Choudhary NS, Saigal S. Preventive strategies for nonalcoholic fatty liver disease after liver transplantation. J Clin Exp Hepatol. 2019;9(5):619-24.[Crossref] [PubMed] [PMC]
- Bernal Bellido C, Suárez Artacho G, Álamo Martínez JM, Marin Gómez LM, Cepeda Franco C, Barrera Pulido L, et al. Incidence and survival rate of de novo tumors in liver transplants. Cir Esp. 2018;96(8):501-7.[Crossref] [PubMed]
- González JP, Zabaleta A, Sangro P, Basualdo JE, Burgos L, Paiva B, et al. Immunophenotypic pattern of de novo malignancy after liver transplantation. Transplant Proc. 2019;51(1):77-9.[Crossref] [PubMed]
- Dumortier J, Maucort-Boulch D, Poinsot D, Thimonier E, Chambon-Augoyard C, Ducroux E, et al. Immunosuppressive regimen and risk for de novo malignancies after liver transplantation for alcoholic liver disease. Clin Res Hepatol Gastroenterol. 2018;42(5):427-35.[Crossref] [PubMed]
- Dąbrowska-Bender M, Kozaczuk A, Pączek L, Milkiewicz P, Słoniewski R, Staniszewska A. Patient quality of life after liver transplantation in terms of emotional problems and the ımpact of sociodemographic factors. Transplant Proc. 2018;50(7):2031-8.[Crossref] [PubMed]
- Tanik A, Demirci F, Güler Doğru, A. [Drug-induced gingival enlargement two case report]. J Dent Fac Atatürk Uni. 2016:26(1):111-6.[Link]
- Gordon FD. 100 Questions and Answers About Liver Transplantation. 1st ed. Canada: Jones and Barlett Publishers; 2007.
- Moya-Nájera D, Borreani S, Moya-Herraiz Á, Calatayud J, López-Andújar R, Colado JC. Is physical exercise harmful to liver transplantation recipients? Review of literature. Cir Esp. 2016;94(1):4-10.[Crossref] [PubMed]
.: Process List